Immunogenicity and Safety of SARS-CoV-2 Recombinant Spike Protein Vaccine in South African People Living with and Without HIV-1 Infection: A Phase 2 Randomised Trial
JOURNAL OF INFECTION(2024)
Key words
COVID-19,Vaccine,Immunosuppression
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined